Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common stock, $0.00001 par value per share
-
Shares outstanding
-
60.4M
-
Number of holders
-
234
-
Total 13F shares, excl. options
-
47M
-
Shares change
-
+3.97M
-
Total reported value, excl. options
-
$5.82B
-
Value change
-
+$483M
-
Put/Call ratio
-
1.33
-
Number of buys
-
130
-
Number of sells
-
-103
-
Price
-
$123.86
Significant Holders of Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) as of Q1 2021
276 filings reported holding TWST - Twist Bioscience Corp - Common stock, $0.00001 par value per share as of Q1 2021.
Twist Bioscience Corp - Common stock, $0.00001 par value per share (TWST) has 234 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47M shares
of 60.4M outstanding shares and own 77.81% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (6.05M shares), BlackRock Inc. (4.05M shares), VANGUARD GROUP INC (3.96M shares), Capital World Investors (3.34M shares), Nikko Asset Management Americas, Inc. (2.06M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.05M shares), Invesco Ltd. (2M shares), JPMORGAN CHASE & CO (1.79M shares), Allianz Asset Management GmbH (1.7M shares), and CREDIT SUISSE AG/ (1.36M shares).
This table shows the top 234 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.